Recurrent Osteosarcoma Completed Phase 1 Trials for Alvocidib (DB03496)

Also known as: Osteosarcoma recurrent / Osteogenic sarcoma recurrent

IndicationStatusPhase
DBCOND0028757 (Recurrent Osteosarcoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00012181Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or LymphomasTreatment